Confluent Health shops amendment to transition term loan B to SOFR

By Sara Rosenberg

New York, June 2 – Confluent Health LLC is seeking a negative consent amendment to its $541 million term loan B due November 2028 (B3/B-) to shift to SOFR from Libor and add a credit spread adjustment, according to a market source.

The CSA being offered is 11.448 basis points one-month rate, 26.161 bps three-month rate and 42.826 bps six-month rate, the source said.

With this amendment, pricing on the term loan will go to SOFR+CSA plus 400 basis points from Libor plus 400 bps.

Deutsche Bank Securities Inc. is the lead on the deal.

The amendment deadline is 5 p.m. ET on Thursday, the source added.

Confluent Health is a Louisville, Ky.-based provider of outpatient physical, employee screening and occupational therapy services.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.